Synthesis, structure-affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.
In a search for high-affinity receptor ligands that might serve for development as radioligands for the imaging of brain 5-HT(4) receptors in vivo with positron emission tomography (PET), structural modifications were made to the high-affinity 5-HT(4) antagonist (1-butylpiperidin-4-yl)methyl 8-amino-7-iodo-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate (1, SB 207710). These modifications were made mainly on the aryl side of the ester bond to permit possible rapid labeling of the carboxylic acid component with a positron emitter, either carbon-11 (t(1/2) = 20.4 min) or fluorine-18 (t(1/2) = 109.7 min), and included (i) replacement of the iodine atom with a small substituent such as nitrile, methyl, or fluoro, (ii) methylation of the 8-amino group, (iii) opening of the dioxan ring, and (iv) alteration of the length of the N-alkyl goup. High-affinity ligands were discovered for recombinant human 5-HT(4) receptors with amenability to labeling with a positron emitter and potential for development as imaging probes. The ring-opened radioligand, (([methoxy-(11)C]1-butylpiperidin-4-yl)methyl 4-amino-3-methoxybenzoate; [(11)C]13), showed an especially favorable array of properties for future evaluation as a PET radioligand for brain 5-HT(4) receptors.
Xu
Rong
R
Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3 C346A, 10 Center Drive, Bethesda, Maryland 20892, USA.
Hong
Jinsoo
J
Morse
Cheryl L
CL
Pike
Victor W
VW
D010129:4-Aminobenzoic Acid / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism; D002250:Carbon Radioisotopes; D002460:Cell Line; D006224:Cricetinae; D054314:Drug Inverse Agonism; D054333:Drug Partial Agonism; D005462:Fluorine Radioisotopes; D006168:Guinea Pigs; D006801:Humans; D007553:Isotope Labeling; D008024:Ligands; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism; D051381:Rats; D044422:Receptors, Serotonin, 5-HT4 / Q000378:metabolism; D058828:Serotonin 5-HT4 Receptor Agonists; D058832:Serotonin 5-HT4 Receptor Antagonists; D013045:Species Specificity; D013329:Structure-Activity Relationship; D062366:para-Aminobenzoates
C553286:(1-butylpiperidin-4-yl)methyl 4-amino-3-methoxybenzoate; D002250:Carbon Radioisotopes; D005462:Fluorine Radioisotopes; D008024:Ligands; D019275:Radiopharmaceuticals; D058828:Serotonin 5-HT4 Receptor Agonists; D058832:Serotonin 5-HT4 Receptor Antagonists; D062366:para-Aminobenzoates; D044422:Receptors, Serotonin, 5-HT4; D010129:4-Aminobenzoic Acid
Mol Imaging Biol. 2003 Nov-Dec;5(6):363-75
14667491
J Psychopharmacol. 1993 Jan;7(2):139-58
22290661
Curr Pharm Des. 2000 Jul;6(10):973-89
10828297
J Med Chem. 2007 Nov 29;50(24):6080-94
17967002
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1670-82
17579853
Mol Imaging Biol. 2003 Nov-Dec;5(6):376-89
14667492
Neuroscience. 1997 Jan;76(2):323-9
9015317
Curr Pharm Des. 2006;12(30):3857-76
17073684
Trends Pharmacol Sci. 1995 Nov;16(11):391-8
8578609
J Nucl Med. 2009 Jun;50(6):900-8
19470850
Neurochem Int. 2009 Dec;55(7):643-7
19540292
Int J Rad Appl Instrum A. 1992 Nov;43(11):1383-5
1333459
Brain Res. 1979 Aug 24;172(2):354-9
466480
J Med Chem. 2004 Oct 21;47(22):5515-34
15481988
J Med Chem. 1993 Dec 10;36(25):4121-3
8258837
Naunyn Schmiedebergs Arch Pharmacol. 1995 Aug;352(2):132-40
7477435
Braz J Psychiatry. 2007 Jun;29(2):148-52
17639254
Mol Pharmacol. 1994 Aug;46(2):227-34
8078486
Chemistry. 2005 Apr 8;11(8):2483-92
15714537
Mol Pharmacol. 2004 Jan;65(1):2-11
14722230
Int Rev Psychiatry. 2007 Oct;19(5):541-58
17896234
J Med Chem. 2003 Jan 30;46(3):319-44
12540230
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1520-8
14579092
Naunyn Schmiedebergs Arch Pharmacol. 1994 May;349(5):546-8
7915008
Trends Pharmacol Sci. 2009 Aug;30(8):431-40
19616318
J Med Chem. 2001 Apr 26;44(9):1396-406
11311062
J Cereb Blood Flow Metab. 2009 Jan;29(1):186-96
18797470
Br J Pharmacol. 1993 Jul;109(3):618-24
8358562
Br J Pharmacol. 2007 Mar;150(6):782-91
17293885
J Nucl Med. 2010 Jan;51(1):112-20
20008988
J Neurosci. 2009 Feb 11;29(6):1937-46
19211900
Synapse. 2004 Aug;53(2):57-67
15170818
J Med Chem. 2008 Sep 25;51(18):5608-16
18754613